human | Q5 |
P6178 | Dimensions author ID | 01107753030.42 |
P496 | ORCID iD | 0000-0002-2041-8557 |
P108 | employer | ETH Zurich | Q11942 |
University of Zurich | Q206702 | ||
Masaryk University | Q763586 | ||
University Hospital of Basel | Q1689257 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q41613329 | An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate |
Q93080090 | Electrospray-Based Microencapsulation of Epigallocatechin 3-Gallate for Local Delivery into the Intervertebral Disc |
Q54307962 | Epigallocatechin 3-gallate suppresses interleukin-1β-induced inflammatory responses in intervertebral disc cells in vitro and reduces radiculopathic pain in rats. |
Q64059523 | Expression and Activity of TRPA1 and TRPV1 in the Intervertebral Disc: Association with Inflammation and Matrix Remodeling |
Q57729339 | Expression and regulation of toll-like receptors (TLRs) in human intervertebral disc cells |
Q37739407 | Nestin expression in human tumors and tumor cell lines. |
Q93209579 | Osmosensing, osmosignalling and inflammation: how intervertebral disc cells respond to altered osmolarity |
Q38988177 | Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems |
Q40014211 | The Natural Polyphenol Epigallocatechin Gallate Protects Intervertebral Disc Cells from Oxidative Stress |
Q55344298 | The Pathobiology of the Meniscus: A Comparison Between the Human and Dog. |
Q52148966 | The effect of serotonin-noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats. |
Q57729296 | The potential of CRISPR/Cas9 genome editing for the study and treatment of intervertebral disc pathologies |
Q57729305 | The role of transient receptor potential channels in joint diseases |
Q58769438 | p38 MAPK Facilitates Crosstalk Between Endoplasmic Reticulum Stress and IL-6 Release in the Intervertebral Disc |
Search more.